B

BridgeBio

Develops therapies for genetic diseases

Associate Director - Patient Advocacy, Skeletal Dysplasia

Biology & BiotechConfirmed live in the last 24 hours
Full-timePortugalNo salary listed

About the Job

Requirements

  • A bachelor's degree is required; a scientific field is preferred.
  • At least 5 years of patient advocacy or community engagement experience, including at least 3 years in biotech or pharma.
  • Experience working with rare disease communities is required; experience with skeletal dysplasia or other genetic rare conditions is preferred.
  • Fluency in Spanish and Portuguese and strong professional English are required.
  • Ability to build trusted partnerships with patient organizations across countries and cultures, ideally including Latin America.
  • Understanding of patient engagement requirements, healthcare systems, and access considerations across international markets.
  • Ability to collaborate cross-functionally, communicate clearly, and manage multiple priorities independently in a matrixed organization.
  • Willingness and ability to travel frequently across Europe, Latin America, and other relevant geographies.

Responsibilities

  • Serve as the primary liaison to patient advocacy organizations in Latin America, Europe, and other international markets, establishing compliant, long-term relationships built on trust, transparency, and alignment.
  • Support the development of the patient advocacy strategy and implement an international patient advocacy plan for skeletal dysplasia aligned with the international plan and local priorities.
  • Represent the company at patient advocacy and community meetings across Europe, Latin America, and other international markets, building and strengthening relationships with patient organizations and local communities.
  • Bring patient and caregiver perspectives into clinical development, medical affairs, regulatory, market access, and commercial planning as appropriate to each program's stage.
  • Plan and deliver engagement activities, including advisory boards, patient organization meetings, educational initiatives, community surveys, patient videos, and opportunities to provide input on patient-facing materials.
  • Adapt engagement and communications for Spanish- and Portuguese-speaking and other international communities, ensuring materials and interactions are culturally relevant and accessible.
  • Support strategic planning and oversight of advocacy-related budgets, including grants, sponsorships, advisory engagements, and educational initiatives.
  • Work with local and international teams to understand differences in care pathways, access barriers, community priorities, and advocacy environments across international markets.
  • Coordinate international grants, sponsorships, advisory engagements, and program budgets in line with applicable policies and local requirements.
  • Share clear, actionable community insights with internal partners while protecting individual privacy, preserving patient trust, and maintaining appropriate boundaries.
  • Monitor and report changes in relevant policies and industry requirements for patient organization engagement and ensure external activities meet company standards and local laws.
  • Promote a patient-first culture by communicating patient and caregiver perspectives, unmet needs, and appropriately consented stories and imagery through internal activities and company materials.
  • Strengthen the company's role as a trusted partner in the skeletal dysplasia advocacy community through presentations and participation in relevant external forums.

Desired Qualifications

  • An advanced degree is preferred.
  • Experience with skeletal dysplasia or other genetic rare conditions is preferred.
  • Familiarity with Europe and Latin American markets is preferred.
  • Knowledge of German and French is an advantage.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs